International Clinical Trial: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of BRP-180 in Patients with Narcolepsy

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000879460) titled 'A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of BRP-180 in Patients with Narcolepsy' on Aug. 12.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Type of endpoint: Safety/efficacy

Primary Sponsor: Bioron Pharma

Condition: Narcolepsy Narcolepsy Neurological - Other neurological disorders

Intervention: This will be a double-blind, multicenter, parallel arm study of low (150mg once daily) and high (225mg once daily) dose levels of BRP-180 as an oral capsule evaluating the change in wakefulness a...